Thrombotic thrombocytopenic purpura developed after pegylated interferon treatment for hepatitis B infection

Thrombotic thrombocytopenic purpura developed after pegylated interferon treatment for hepatitis B infection

Abstract Background Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopathy characterized by microangiopathic hemolytic anemia, severe thrombocytopenia, and organ ischemia. It is related to severe deficiency in ADAMTS13, which is usually acquired via ADAMT...

Full description

Bibliographic Details
Main Authors: Shuqin Mei, Yun Feng, Linlin Cui, Jing Chen, Zhiguo Mao, Xuezhi Zhao, Changlin Mei, Yixin Qian
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Nephrology
Subjects:
Thrombotic microangiopathy
Thrombotic thrombocytopenic purpura
Hepatitis B
Pegylated interferon
COVID-19 vaccination
Online Access:https://doi.org/10.1186/s12882-022-03034-9

Internet

https://doi.org/10.1186/s12882-022-03034-9

Similar Items